If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
The University of Virginia's Dr. Anita Clayton has been a primary investigator for nearly every antidepressant approved in ...
If you’re struggling with depression, the most important question about taking an antidepressant is whether it will work. But ...
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Conditions like heart failure, kidney problems, or hormonal fluctuations can cause the body to retain excess fluid, leading ...
Most people experience mild symptoms if they ... The table below lists some common antidepressants and shows the approximate time it may take for half of the drug to leave your body (also ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Johnson & Johnson (JNJ) stock in focus as FDA expands the label for its depression therapy Spravato (esketamine) allowing its ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
A woman who said she has become severely suicidal during a year of being prescribed the same antidepressants as royal family ...